132 related articles for article (PubMed ID: 35430343)
1. The relationship among integrin alpha 7, CD133 and Nestin as well as their correlation with clinicopathological features and prognosis in astrocytoma patients.
Li C; Liu J; Yang W; Chen C; Wu B
Clin Neurol Neurosurg; 2022 Jun; 217():107198. PubMed ID: 35430343
[TBL] [Abstract][Full Text] [Related]
2. ITGA7, CD133, ALDH1 are inter-correlated, and linked with poor differentiation, lymph node metastasis as well as worse survival in surgical cervical cancer.
Yuan N; Wang L; Xi Q; Zou N; Zhang X; Lu X; Zhang Z
J Obstet Gynaecol Res; 2022 Apr; 48(4):1011-1018. PubMed ID: 35194895
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival.
Zhang Q; Xu B; Chen J; Chen F; Chen Z
J Clin Lab Anal; 2020 Mar; 34(3):e23082. PubMed ID: 31677196
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
5. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
6. Integrin-α7 expression positively correlates with CD44 and CD133 expressions, and its high expression associates with advanced tumor features as well as poor survivals in non-small cell lung cancer patients.
Shi X; Wen F; Xu G; Hu Y
Transl Cancer Res; 2019 Sep; 8(5):1806-1816. PubMed ID: 35116931
[TBL] [Abstract][Full Text] [Related]
7. Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.
Lv Z; Yang Y; Yang C
Int J Oncol; 2020 Jan; 56(1):69-84. PubMed ID: 31789398
[TBL] [Abstract][Full Text] [Related]
8. Integrin α7 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer.
Bai X; Gao C; Zhang L; Yang S
J Clin Lab Anal; 2019 Oct; 33(8):e22979. PubMed ID: 31325216
[TBL] [Abstract][Full Text] [Related]
9. Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer.
Xia D; Chen B; Yang X
J Clin Lab Anal; 2019 Oct; 33(8):e22973. PubMed ID: 31418948
[TBL] [Abstract][Full Text] [Related]
10. Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas.
Zambo I; Hermanova M; Zapletalova D; Skoda J; Mudry P; Kyr M; Zitterbart K; Sterba J; Veselska R
Cancer Biomark; 2016 Jun; 17(1):107-16. PubMed ID: 27314299
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
Sabet MN; Rakhshan A; Erfani E; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
[TBL] [Abstract][Full Text] [Related]
12. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
[TBL] [Abstract][Full Text] [Related]
13. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
[TBL] [Abstract][Full Text] [Related]
14. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of CD133 and nestin in patients with glioma: a population-based study.
Dahlrot RH; Hansen S; Jensen SS; Schrøder HD; Hjelmborg J; Kristensen BW
Int J Clin Exp Pathol; 2014; 7(7):3739-51. PubMed ID: 25120750
[TBL] [Abstract][Full Text] [Related]
16. What is the clinical value of cancer stem cell markers in gliomas?
Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
Shin JH; Lee YS; Hong YK; Kang CS
J Neurooncol; 2013 Dec; 115(3):333-41. PubMed ID: 24129546
[TBL] [Abstract][Full Text] [Related]
18. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma.
Sabunga OD; Kaelan C; Zainuddin AA; Sungowati NK; Cangara MH; Miskad U
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3051-3059. PubMed ID: 36172668
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.
Ge JC; Wang YX; Chen ZB; Chen DF
Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
